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ABSTRACT 
Significance of ECM as a regulator of vascular function has been hypothesized but not fully 
investigated. We assessed vessel stability and response to acute tissue stress in vivo in mice where 
type I collagen metabolism is altered due to presence of a knock-in mutation in the Col1a1 gene, 
e.g., Col 1(I)r/r mice. Our data revealed that plasma protein extravasation and vessel leakiness 
following acute stimulation of skin by topical exposure to mustard oil (MO) or intradermal injection 
of serotonin, histamine or VEGF-A, in Col 1(I)r/r mice was attenuated by 50% indicating that vessels 
resist acute responses due to maintenance of stability. We found that maintenance of vessel stability 
in Col 1(I)r/r mice was due to chronic activation of a metalloprotease (MP) in skin since treatment of 
Col 1(I)r/r mice with the MP inhibitor GM6001 restored acute vascular responses to mutant animals. 
We assessed vascular leakage in MMP-2, -8, -13 and -14-deficient mice and found that only in 
MMP14-deficient mice was vessel stability compromised as evidenced by their increased steady state 
level of plasma protein leakage. To reveal the molecular pathway being regulated by MMP14, we 
treated Col 1(I)r/r mice with neutralizing antibodies to TGFß or an ALK5 inhibitor and found that 
vascular responsiveness in Col 1(I)r/r mice was normalized to characteristic levels as observed in wt 
mice. The implications of these findings are that pharmacologic manipulation of type I collagen 
metabolism, MMP14 activity, or TGFß-induced signaling represents efficacious targets for regulating 
vascular stability and/or leakiness in vivo.  
 
